These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases. Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073 [TBL] [Abstract][Full Text] [Related]
11. The use of proteomics in biomarker discovery in neurodegenerative diseases. Davidsson P; Sjögren M Dis Markers; 2005; 21(2):81-92. PubMed ID: 15920295 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Shaw LM; Korecka M; Clark CM; Lee VM; Trojanowski JQ Nat Rev Drug Discov; 2007 Apr; 6(4):295-303. PubMed ID: 17347655 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers of neurodegenerative disorders: how good are they? Rachakonda V; Pan TH; LE WD Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease. Schaffer C; Sarad N; DeCrumpe A; Goswami D; Herrmann S; Morales J; Patel P; Osborne J J Lab Autom; 2015 Oct; 20(5):589-600. PubMed ID: 25424384 [TBL] [Abstract][Full Text] [Related]
15. Enlightening the advancements in electrochemical bioanalysis for the diagnosis of Alzheimer's disease and other neurodegenerative disorders. Serafín V; Gamella M; Pedrero M; Montero-Calle A; Razzino CA; Yáñez-Sedeño P; Barderas R; Campuzano S; Pingarrón JM J Pharm Biomed Anal; 2020 Sep; 189():113437. PubMed ID: 32629192 [TBL] [Abstract][Full Text] [Related]
16. Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy. Dupiereux I; Zorzi W; Quadrio I; Perret-Liaudet A; Kovacs GG; Heinen E; Elmoualij B Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):2-11. PubMed ID: 20021333 [TBL] [Abstract][Full Text] [Related]
17. Disposable immunoplatforms for the simultaneous determination of biomarkers for neurodegenerative disorders using poly(amidoamine) dendrimer/gold nanoparticle nanocomposite. Serafín V; Razzino CA; Gamella M; Pedrero M; Povedano E; Montero-Calle A; Barderas R; Calero M; Lobo AO; Yáñez-Sedeño P; Campuzano S; Pingarrón JM Anal Bioanal Chem; 2021 Jan; 413(3):799-811. PubMed ID: 32474723 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers in Neurodegenerative Diseases. Jeromin A; Bowser R Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995 [TBL] [Abstract][Full Text] [Related]
19. [Correlation between Alzheimer disease and cataract]. Liu SS; Zhu SQ Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):314-316. PubMed ID: 28412806 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects. Cedazo-Minguez A; Winblad B Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]